Clinical trials recruiting for Protein Kinase Inhibitors
Fewer than 3 recruiting trials found.
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| JYP0322 100 mg bid | 1 |
| JYP0322 100 mg qd | 1 |
| JYP0322 150 mg bid | 1 |
| JYP0322 150mg tid | 1 |
| JYP0322 200 mg bid | 1 |
| JYP0322 200 mg qd | 1 |
| JYP0322 50 mg qd | 1 |
Self-screener
Recruiting trials
Related conditions
Trials recruiting for Protein Kinase Inhibitors often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Protein Kinase Inhibitors trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.